the next resmed, page-6

AsthmaSense on Google store, after 2 moonths, has managed somewhere between 10 and 50 downloads. Almost 2 months on iTunes and there have been just 6 reviews (most likely predominantly from posters here). Dismal failure at making people aware of it, so now MF moves onto this becoming the next ResMed...lol. Let's start more conservatively shall we. Let's hope it can get out of penny stock status to begin with, then profitable, and then we can start talking about its potential besides other Australian Bio success stories.

These sort of headline threads should be banned. They serve little purpose and just make potential investors even more wary.